StockData
RenovoRx, Inc. logo

RenovoRx, Inc. (RNXT) stock

RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.04+0.09 (+8.91%)

Close on Nov 17, 2026Market cap $46.93MP/E –Yield –

RenovoRx market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

RenovoRx's market cap was $55.05M on Nov 11, 2026, against $33.62M a year earlier. Over the last 5 years it ranged from $6.84M to $87.09M, with a median of $25.41M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$55.05M+78.8%
2025Dec 31, 2025$30.79M-0.6%
2024Dec 31, 2024$30.96M+26.4%
2023Dec 29, 2023$24.49M+14.9%
2022Dec 30, 2022$21.32M-50.6%
2021Dec 31, 2021$43.12M–

More RenovoRx figures

See a number that looks wrong?